| Literature DB >> 28275516 |
Amr S Fayad1, Mohamed G Elsheikh1, Waleed Ghoneima1.
Abstract
OBJECTIVE: To assess the safety, efficacy, and stone-free rate (SFR) of mini-percutaneous nephrolithotomy (mini-PCNL) and retrograde intrarenal surgery (RIRS) for the management of lower calyceal stones of ⩽2 cm, and to determine the advantages and disadvantages of each. PATIENTS AND METHODS: In all, 120 patients with lower calyceal stones of ⩽2 cm were randomly divided into two equal groups: Group A were managed by mini-PCNL and Group B by RIRS using flexible ureteroscopy and laser. The mean age, sex, stone size, operating time, complications, hospital stay, and SFR were compared between the groups. The success of the procedure was defined as the absence of residual stones or small residuals of ⩽0.2 cm on computed tomography at 12 weeks postoperatively.Entities:
Keywords: Ho:YAG, holmium:yttrium-aluminium-garnet; KUB, plain abdominal radiograph of the kidneys, ureters and bladder; PCNL; PCNL, percutaneous nephrolithotomy; RIRS; RIRS, retrograde intrarenal surgery; Renal stones; SFR, stone-free rate; SWL, shockwave lithotripsy; mini-PCNL
Year: 2016 PMID: 28275516 PMCID: PMC5329753 DOI: 10.1016/j.aju.2016.10.002
Source DB: PubMed Journal: Arab J Urol ISSN: 2090-598X
The patients’ preoperative characteristics.
| Variable | Group A (mini-PCNL) | Group B (RIRS) | |
|---|---|---|---|
| Sex, | 0.727 | ||
| Males | 38 (63.3) | 34 (56.7) | |
| Females | 22 (36.7) | 26 (43.3) | |
| Mean (SD; range): | |||
| Age, years | 37.23 (9.24; 20–56) | 37.7 (9.76; 19–57 | 0.981 |
| Stone size, cm | 1.47 (0.3; 0.8–2.0) | 1.41 (0.3; 0.8–20) | 0.392 |
| Preoperative Hb, g/dL, mean (SD; range) | 13.78 (0.797; 12.3–15.3) | 13.69 (0.755; 12.4–15.0) | 0.796 |
| Right-sided stones, | 34 (56.7) | 38 (63.3) | 0.727 |
Hb, haemoglobin.
The patients’ operative and postoperative characteristics.
| Variable | Group A (mini-PCNL) | Group B (RIRS) | |
|---|---|---|---|
| Mean (SD; range): | |||
| Operating time, min | 71.66 (10.36) | 109.66 (20.75) | <0.001 |
| Postoperative Hb level, g/dL | 13.15 (0.813; 11.3–14.6) | 13.56 (0.781; 12.2–15.0) | 0.081 |
| Patients stone free at 12-week follow-up, | 51/55 | 43/51 | 0.060 |
| SFR,% | 92.72 | 84.31 | |
| Complications, | |||
| Overall intraoperative | 3 (5) | 2 (3.33) | 0.187 |
| Bleeding | 2 (3.33) | 0 | |
| Minor mucosal injury | 1 (1.66) | 2 (3.33) | |
| Postoperative fever | 2 (3.33) | 3 (5) | 0.227 |
| Total complications | 5 (8.33) | 5 (8.33) | 1 |
Hb, haemoglobin.
Figure 1Consolidated Standards of Reporting Trials (CONSORT) flow chart of study participants.